Pasithea Therapeutics Corp. financial data

Symbol
KTTA, KTTAW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Lincoln Road, Suite 500, Miami Beach, FL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 691 % -35.4%
Debt-to-equity 8.91 % +7.61%
Return On Equity -81 % -60.5%
Return On Assets -74.4 % -59.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.71M shares +160%
Common Stock, Shares, Outstanding 1.39M shares +33.9%
Entity Public Float 4.1M USD -61%
Common Stock, Value, Issued 139 USD +33.7%
Weighted Average Number of Shares Outstanding, Basic 1.1M shares -10.6%
Weighted Average Number of Shares Outstanding, Diluted 1.1M shares -10.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.2M USD -11.1%
General and Administrative Expense 1.42M USD -34.2%
Operating Income (Loss) -14.2M USD +10.8%
Nonoperating Income (Expense) 345K USD -26.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.9M USD +10.3%
Net Income (Loss) Attributable to Parent -13.9M USD +12.9%
Earnings Per Share, Basic -0.42 USD/shares +76.1%
Earnings Per Share, Diluted -0.42 USD/shares +76.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.92M USD -57.6%
Other Assets, Current 143K USD +36.5%
Assets, Current 7.37M USD -55.9%
Property, Plant and Equipment, Net 122K USD -13.4%
Operating Lease, Right-of-Use Asset 32K USD -93%
Intangible Assets, Net (Excluding Goodwill) 7.31M USD -7.94%
Goodwill 1.26M USD 0%
Assets 16.1M USD -38.5%
Liabilities, Current 1.12M USD -57.5%
Operating Lease, Liability, Noncurrent 211K USD -70.9%
Liabilities 1.28M USD -52.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.17K USD -54.1%
Retained Earnings (Accumulated Deficit) -49.6M USD -40.4%
Stockholders' Equity Attributable to Parent 14.8M USD -36.8%
Liabilities and Equity 16.1M USD -38.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities 264K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.39M shares +33.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.32M USD -36.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.92M USD -57.6%
Deferred Tax Assets, Valuation Allowance 0 USD
Deferred Tax Assets, Gross 11.8M USD +54.6%
Operating Lease, Liability 33K USD -92.9%
Depreciation 4.72K USD +12.9%
Payments to Acquire Property, Plant, and Equipment 53.9K USD +2662%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.9M USD +12.9%
Lessee, Operating Lease, Liability, to be Paid 33.3K USD
Property, Plant and Equipment, Gross 165K USD 0%
Operating Lease, Liability, Current 33K USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 83.3K USD -72%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 323 USD -99.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 183K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 64.4M USD +9.62%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +53.6%
Share-based Payment Arrangement, Expense 176K USD +18.6%
Operating Leases, Future Minimum Payments Due 83.3K USD
Interest Expense -117K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%